Role of NOS3 in the Cerebrovascular Response to TBI
NOS3 在 TBI 脑血管反应中的作用
基本信息
- 批准号:7237924
- 负责人:
- 金额:$ 29.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-15 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:AreaArginineAttenuatedBloodBrainCarbon DioxideCerebrospinal FluidCerebrovascular SpasmCerebrumClinical ResearchCodeComplexCore-Binding FactorCritical CareCritical IllnessDataDatabasesDiseaseEnd PointEnrollmentEvaluationFunctional disorderFutureGeneral HospitalsGenesGeneticGenetic PolymorphismGenetic VariationGenotypeGlasgow Outcome ScaleHomeostasisHumanImpairmentIndividualInjuryInvestigationLinkMeasuresMedicineMicrodialysisMusNOS3 geneNumbersOutcomeOutcome MeasurePatient CarePatientsPerfusionPhysiologicalPlasmaPlayPopulationProtein IsoformsRateResearch PersonnelRoleSample SizeSamplingScoreSepsisShockSubarachnoid HemorrhageSusceptibility GeneTBI PatientsTestingTissuesTranscriptTraumatic Brain InjuryVariantWild Type MouseWorkbasecerebrovasculardisabilityfunctional outcomeshuman NOS3 proteininjuredinterestpressureprogramsresponse
项目摘要
DESCRIPTION (provided by applicant): Although severe traumatic brain injury (TBI) is not a disease with "susceptibility genes" in the usual sense, the response to TBI is a complex interaction among the injury, the individual patient's genotype, and the treatment that we provide. Increasingly in critical care medicine, emphasis is being placed on understanding the role that an individual's genetic makeup plays in the response to critical illness and injury, and also in response to therapies that we use to treat these disorders. Most of this work to date has concentrated on the response of the body to shock and to sepsis. Relatively little work has been done in the area of TBI. In this proposal, we plan a clinical study, using the expertise that we have in the cerebrovascular pathophysiology of TBI and the large population of TBI patients that we care for at Ben Taub General Hospital, to examine the role of polymorphisms of the NOS3 gene in the cerebrovascular response to severe TBI. In addition, we will contribute to an established tissue/data bank unused blood, cerebrospinal fluid, and cerebral microdialysis samples from the patients so that future investigations of other genes and transcripts of interest can take advantage of the prospectively collected functional evaluation of the cerebrovascular response of the patients enrolled in this study. The following three specific aims are proposed: Specific Aim #1 is to study the role of polymorphisms of the NOS3 gene in the cerebrovascular response to human traumatic brain injury. Specific Aim #2 is to study the role of polymorphisms of the NOS3 gene in the response of cerebral vasculature to administration of L-arginine. Specific Aim #3 is to store unused blood, cerebrospinal fluid, and microdialysis samples in an established tissue/data bank with a coded link to the demographic/physiological/treatment and genetic data that is collected with this proposal for future studies of other genes and transcripts that may become of interest.
描述(由申请人提供):虽然严重创伤性脑损伤(TBI)不是通常意义上的“易感基因”疾病,但对TBI的反应是损伤、个体患者的基因型和我们提供的治疗之间的复杂相互作用。在重症监护医学中,越来越多的人强调理解个体的基因组成在应对重症疾病和损伤中的作用,以及我们用于治疗这些疾病的治疗方法。迄今为止,这项工作的大部分集中在身体对休克和脓毒症的反应上。在创伤性脑损伤领域所做的工作相对较少。在这个提议中,我们计划进行一项临床研究,利用我们在脑血管病理生理学方面的专业知识和我们在Ben Taub综合医院护理的大量TBI患者,来研究NOS 3基因多态性在脑血管对严重TBI的反应中的作用。此外,我们将为已建立的组织/数据库提供患者未使用的血液、脑脊液和脑微透析样本,以便将来对其他感兴趣的基因和转录本的研究可以利用前瞻性收集的本研究入组患者脑血管反应的功能评价。提出了以下三个具体目标:具体目标#1是研究NOS 3基因多态性在人类创伤性脑损伤的脑血管反应中的作用。具体目标#2是研究NOS 3基因多态性在脑血管系统对施用L-精氨酸的反应中的作用。具体目标#3是将未使用的血液、脑脊液和微透析样本储存在已建立的组织/数据库中,并与人口统计学/生理学/治疗和遗传数据进行编码链接,这些数据是与本提案一起收集的,用于未来可能感兴趣的其他基因和转录本的研究。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
L-arginine reactivity in cerebral vessels after severe traumatic brain injury.
严重脑外伤后脑血管中的 L-精氨酸反应性。
- DOI:10.1179/016164110x12767786356598
- 发表时间:2010
- 期刊:
- 影响因子:1.9
- 作者:Rangel-Castilla,Leonardo;Ahmed,Osama;Goodman,JClay;Gopinath,Shankar;Valadka,Alex;Robertson,Claudia
- 通讯作者:Robertson,Claudia
Variants of the endothelial nitric oxide gene and cerebral blood flow after severe traumatic brain injury.
- DOI:10.1089/neu.2010.1476
- 发表时间:2011-05
- 期刊:
- 影响因子:4.2
- 作者:C. Robertson;S. Gopinath;A. Valadka;M. Van;P. Swank;J. Goodman
- 通讯作者:C. Robertson;S. Gopinath;A. Valadka;M. Van;P. Swank;J. Goodman
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLAUDIA S ROBERTSON其他文献
CLAUDIA S ROBERTSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLAUDIA S ROBERTSON', 18)}}的其他基金
31st Annual National Neurotrauma Society(NNS)Symposium
第 31 届国家神经创伤协会 (NNS) 年度研讨会
- 批准号:
8596881 - 财政年份:2013
- 资助金额:
$ 29.6万 - 项目类别:
AN ERYTHROPOIETIN-MIMETIC PEPTIDE (pHBSP) FOR TREATMENT OF TBI
用于治疗 TBI 的促红细胞生成素模拟肽 (pHBSP)
- 批准号:
8703819 - 财政年份:2013
- 资助金额:
$ 29.6万 - 项目类别:
AN ERYTHROPOIETIN-MIMETIC PEPTIDE (pHBSP) FOR TREATMENT OF TBI
用于治疗 TBI 的促红细胞生成素模拟肽 (pHBSP)
- 批准号:
8437303 - 财政年份:2013
- 资助金额:
$ 29.6万 - 项目类别:
Effect of Eythropoietin on Vascular Dysfunction in Human TBI
促红细胞生成素对人 TBI 血管功能障碍的影响
- 批准号:
7018083 - 财政年份:2006
- 资助金额:
$ 29.6万 - 项目类别:
Neuroprotection of Erythropoietin Signaling in TBI
TBI 中促红细胞生成素信号传导的神经保护
- 批准号:
7018085 - 财政年份:2005
- 资助金额:
$ 29.6万 - 项目类别:
Role of NOS3 in the Cerebrovascular Response to TBI
NOS3 在 TBI 脑血管反应中的作用
- 批准号:
6948266 - 财政年份:2004
- 资助金额:
$ 29.6万 - 项目类别:
Role of NOS3 in the Cerebrovascular Response to TBI
NOS3 在 TBI 脑血管反应中的作用
- 批准号:
7061320 - 财政年份:2004
- 资助金额:
$ 29.6万 - 项目类别:
Role of NOS3 in the Cerebrovascular Response to TBI
NOS3 在 TBI 脑血管反应中的作用
- 批准号:
6873344 - 财政年份:2004
- 资助金额:
$ 29.6万 - 项目类别:
Regulation of Cerebral Blood Flow After Traumatic Brain Injury
脑外伤后脑血流的调节
- 批准号:
6613365 - 财政年份:2002
- 资助金额:
$ 29.6万 - 项目类别:
Arginine treatment of a reduced cerebral blood flow after traumatic brain injury
精氨酸治疗脑外伤后脑血流量减少
- 批准号:
6613367 - 财政年份:2002
- 资助金额:
$ 29.6万 - 项目类别:
相似国自然基金
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
- 批准号:
489995 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Operating Grants
The role of protein arginine methyl transferase PRMT1 on myelin development
蛋白精氨酸甲基转移酶PRMT1对髓磷脂发育的作用
- 批准号:
23K14287 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer
使用 Sepiaptein 使精氨酸代谢正常化以实现 HER2 乳腺癌的免疫刺激转变
- 批准号:
10776256 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
精氨酸消耗联合铂类紫杉烷化疗对侵袭性变异前列腺癌 (AVPC) 的影响
- 批准号:
10715329 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
- 批准号:
10668754 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Physiological function of arginine signaling:macropinocytosisand tumor immune evasion
精氨酸信号的生理功能:巨胞饮作用与肿瘤免疫逃避
- 批准号:
23H03317 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
- 批准号:
498862 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Operating Grants
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Arginine methylation of the RNA helicase DDX5 in the regulation of RNA/DNA hybrids during the DNA damage response.
RNA 解旋酶 DDX5 的精氨酸甲基化在 DNA 损伤反应期间调节 RNA/DNA 杂交体中的作用。
- 批准号:
487619 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Operating Grants
Regulation of and Target Recognition by Protein Arginine Methyltransferase 1 (PRMT1)
蛋白质精氨酸甲基转移酶 1 (PRMT1) 的调节和目标识别
- 批准号:
10653465 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别: